Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
For full access to this article login to GEN Select now.
Biomanufacturers Confront Big Data Issues
Superior Data Management Essential to Achieving Operational Efficiencies
- Bioprocessing is a major growth industry within the life sciences. But why is this cell growth industry emerging so quickly? The rise in large molecule therapeutics, vaccines, and biosimilars has been rapid, but the FDA has fed the sector with its Quality by Design (QbD) requirements backed up ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.